ORIC PharmaceuticalsListed
oricpharma.combiotech_life_sciences
ORIC Pharmaceuticals is focused on developing and commercializing innovative therapies that target cancer resistance mechanisms, aiming to enhance the efficacy and longevity of ex…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
ORIC Pharmaceuticals is focused on developing and commercializing innovative therapies that target cancer resistance mechanisms, aiming to enhance the efficacy and longevity of ex…
Tenaya Therapeutics is a clinical-stage biotech company focused on developing gene therapies for heart diseases. It aims to discover, develop, and deliver potentially curative the…
Arcus Biosciences is a clinical-stage biopharmaceutical company focused on developing best-in-class combination therapies for cancer. The company utilizes a deep understanding of…
Nurix Therapeutics is focused on developing targeted protein degradation therapies to treat various diseases, leveraging their DEL-AI drug discovery engine to create innovative me…
Revolution Medicines is dedicated to discovering, developing, and delivering innovative, targeted medicines for patients living with RAS-addicted cancers. They focus on pioneering…
Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and developing breakthrough therapeutics through the purposeful integration of science and engineer…
Surrozen is pioneering therapies that harness the power of Wnt signaling to treat sight-threatening ophthalmic conditions. The company develops multi-target antibody therapeutics…
Kallyope focuses on developing innovative medicines for neurological and metabolic disorders, leveraging insights into neural signaling pathways.
NGM Bio is a biopharmaceutical company focused on developing novel, life-changing medicines for people whose health and lives have been disrupted by disease.
Circle Pharma is dedicated to transforming cancer treatment through the power of macrocycles, aiming to create effective therapies that minimize side effects for patients.
Synthekine is a biotechnology company focused on discovering, developing, and commercializing selective cytokine therapeutics to treat cancer and autoimmune diseases.
Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. Based on a novel neu…
RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory an…
Carmot Therapeutics is a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases, including obesity and d…
Topo Therapeutics is a biotechnology company focused on accelerating transmembrane protein drug discovery. The firm leverages advances in protein purification, structural determin…
Nilo Therapeutics is an early-stage biotech company developing groundbreaking therapies for autoimmune and inflammatory diseases. The company focuses on modulating immune response…
We are delivering transformative therapies by harnessing the potential of covalent medicines and chemical proteomics coupled with deep human translational insights.
Synthex provides a platform for financial institutions to automate regulated work with built-in governance and evidence generation. It orchestrates processes across teams and inte…
Tortugas Neuroscience is focused on developing novel medicines targeting complex brain disorders with large, well-defined patient populations. The company’s strategy centers on le…
Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new RNA medicines for systemic and renal diseases. With our STRIKE (Selectively Targe…
Remix Therapeutics is advancing a new class of therapeutics by modulating RNA processing with small molecules. The company focuses on drug discovery programs that target previousl…
A2 Biotherapeutics is advancing its Tmod™ cell engineering platform to create precision CAR T-cell therapies, focusing on restoring health and hope for patients with cancer and ot…
Accent is leading the translation of RNA-modifying protein (RMP) biology into promising new therapies by combining a robust chemical biology platform with rigorous approaches to t…
Nura Bio is focused on revolutionizing the treatment of neurological diseases with novel, life-changing neuroprotective medicines, targeting pathways underlying axon degeneration…
Plexium is a biotechnology research company focused on targeted protein degradation (TPD). It develops small-molecule therapeutics, including monovalent direct degraders and molec…
Cajal Therapeutics is a Seattle-based biotechnology company dedicated to developing innovative medicines for serious diseases. Our team brings together deep expertise in genetics,…
Hexagon Bio is developing novel ADC payload mechanisms to overcome resistance to today’s payloads and expand the indication space for ADCs, focusing on targeted cytotoxic therapy…
Tr1X is a private, clinical-stage biotechnology company focused on developing a novel class of regulatory T cell-based products to cure autoimmune and inflammatory diseases. The c…
Lyterian Therapeutics focuses on biotechnology and small molecule therapeutics within the healthcare sector. The company develops medicines by using protein homeostatic mechanisms…
Kimia provides chemical intelligence solutions that connect fragmented product and regulatory knowledge to enhance commercial decision-making and portfolio performance in the chem…
Gritstone bio is a biotechnology company focused on developing innovative immune-based treatments for cancer and infectious diseases, leveraging insights into the immune system to…
Kenai Therapeutics is focused on revolutionizing neurodegenerative treatments using induced pluripotent stem cell (iPSC) technology to develop new cell replacement and gene-modifi…
Peloton Therapeutics is a biotechnology company focused on developing innovative therapies for cancer treatment through its proprietary drug discovery platform.
Aragon Pharmaceuticals is focused on the development of second-generation anti-hormonal agents for hormone-driven cancers, including its lead compound ARN-509 for prostate cancer…
Seragon is focused on developing new treatments for estrogen-driven cancers based on its Selective Estrogen Receptor Degrader (SERD) platform. The company aims to create orally ac…
Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medica…
Exonics Therapeutics is developing gene editing therapies to treat patients with Duchenne Muscular Dystrophy (DMD) and other severe genetic neuromuscular diseases, utilizing Singl…
Flexus Biosciences is a biotechnology company focused on the discovery, development, and commercialization of novel anti-cancer therapeutics, leveraging insights in immunology to…
Escient Pharmaceuticals is a clinical-stage biotechnology company focused on developing GPCR-targeted therapies for neurosensory-inflammatory disorders. The company is advancing f…
Details are not available yet. The company remains listed.
InduPro specializes in proximity-based therapeutics, focusing on the spatial relationships of proteins on cell surfaces to develop innovative drug therapies.
Vaderis Therapeutics is a Swiss biopharmaceutical company focused on rare vascular diseases, developing VAD044 for Hereditary Hemorrhagic Telangiectasia (HHT).
Atavistik Bio is involved in the discovery and development of allosteric therapeutics within the biotechnology sector. The company has a drug discovery platform that identifies an…